Dow Down 0.14% Nasdaq Down 0.18%

Inovio Pharmaceuticals, Inc. (INO)

-NYSE MKT
10.68 Up 0.10(0.95%) 9:46AM EDT - Nasdaq Real Time Price
Prev Close:10.58
Open:10.63
Bid:10.61 x 400
Ask:10.62 x 100
1y Target Est:21.00
Beta:3.38
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:10.42 - 10.68
52wk Range:6.40 - 15.80
Volume:77,702
Avg Vol (3m):1,897,490
Market Cap:645.05M
P/E (ttm):N/A
EPS (ttm):-1.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for INO

Comparison

Symbol% ChgMkt Cap
INOUp 0.95%645.05M
AZNDown 0.05%92.39B
PFEUp 0.24%183.19B
SNYDown 1.64%138.72B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):36.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.63
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback